Kentucky Retirement Systems’s BioMarin Pharmaceuticals BMRN Stock Holding History

Kentucky Retirement Systems’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$687K	Buy	+12,002	New	+$657K	0.02%	479
2026 Q1	–	Sell	-11,936	Closed	-$709K	–	522
2025 Q4	$709K	Hold	11,936	–	–	0.02%	477
2025 Q3	$646K	Sell	11,936 -161	-1%	-$9.21K	0.02%	484
2025 Q2	$665K	Sell	12,097 -793	-6%	-$46.7K	0.02%	474
2025 Q1	$911K	Buy	+12,890	New	+$867K	0.03%	454

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Kentucky Retirement Systems's BMRN Position: Q2 2026 in Review

Kentucky Retirement Systems opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 12,002 shares worth $687K. The stake represents 0.02% of the portfolio and ranks #479 among its holdings. This is a return to the name: Kentucky Retirement Systems previously reported a position in BMRN as recently as Q4 2025.

Kentucky Retirement Systems first reported a position in BMRN in Q1 2025 and has held it in 5 quarters since. The position peaked at $911K in Q1 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Kentucky Retirement Systems held 12,002 shares of BioMarin Pharmaceuticals worth $687K as of Q2 2026.
BioMarin Pharmaceuticals was a new Kentucky Retirement Systems position in Q2 2026.
BioMarin Pharmaceuticals made up 0.02% of Kentucky Retirement Systems's portfolio in Q2 2026, its #479 holding.
Kentucky Retirement Systems first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
Kentucky Retirement Systems's BioMarin Pharmaceuticals position peaked at $911K in Q1 2025.
564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Kentucky Retirement Systems's 13F filing for Q2 2026, filed 14 Aug 2026.